High prevalence of orthostatic hypotension in mild dementia

Dementia and Geriatric Cognitive Disorders

Volumn 28, Issue 4, 2009, Pages 307-313

  Sonnesyn, Hogne ^a   Nilsen, Dennis W ^b,g   Rongve, Arvid ^d   Nore, Sabine ^e   Ballard, Clive ^h   Tysnes, Ole B ^f,g   Aarsland, Dag ^c,g  

^a Department of Internal Medicine

^b Department of Cardiology ^*

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d HAUGESUND HOSPITAL   (Norway)

^e Haraldsplass Deaconess (University) Hospital   (Norway)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF BERGEN   (Norway)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Dementia; Electrocardiography; Hypotension; Orthostatic; QTc

Indexed keywords

AMIODARONE; PHENOTHIAZINE; SOTALOL; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DEMENTIA; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QT PROLONGATION; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; COHORT STUDIES; DEMENTIA; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; LEWY BODY DISEASE; LONG QT SYNDROME; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES;

EID: 70349890468     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000247586     Document Type: Article

References (52)

1. Aarsland D, Rongve A, Nore SP, Skogseth R, Skulstad S, Ehrt U, Hoprekstad D, Ballard C: Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement Geriatr Cogn Disord 2008; 26: 445-452.
2. Zaccai J, McCracken C, Brayne C: A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 2005; 34: 561-566. (Pubitemid 41699997)
3. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M: Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863-1872.
4. Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA: Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry 2007; 78: 671-677.
5. Thaisetthawatkul P, Boeve BF, Benarroch EE, Sandroni P, Ferman TJ, Petersen R, Low PA: Autonomic dysfunction in dementia with Lewy bodies. Neurology 2004; 62: 1804-1809.
6. Low PA, Opfer-Gehrking TL, McPhee BR, Fealey RD, Benarroch EE, Willner CL, Suarez GA, Proper CJ, Felten JA, Huck CA, et al: Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995; 70: 617-622.
7. Morris JC, Rubin EH, Morris EJ, Mandel SA: Senile dementia of the Alzheimer's type: an important risk factor for serious falls. J Gerontol 1987; 42: 412-417.
8. Shaw FE: Prevention of falls in older people with dementia. J Neural Transm 2007; 114: 1259-1264.
9. Ballard CG, Shaw F, Lowery K, McKeith I, Kenny R: The prevalence, assessment and associations of falls in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 1999; 10: 97-103. (Pubitemid 29099692)
10. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus committee of the American Autonomic Society and the American Academy of Neurology. Neurology 1996; 46: 1470.
11. Andersson M, Hansson O, Minthon L, Ballard CG, Londos E: The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies. Int J Geriatr Psychiatry 2008; 23: 192-198.
12. Browne KF, Zipes DP, Heger JJ, Prystowsky EN: Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol 1982; 50: 1099-1103.
13. Whitsel EA, Boyko EJ, Siscovick DS: Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis. Diabetes Care 2000; 23: 241-247.
14. Choy AM, Lang CC, Roden DM, Robertson D, Wood AJ, Robertson RM, Biaggioni I: Abnormalities of the QT interval in primary disorders of autonomic failure. Am Heart J 1998; 136: 664-671.
15. Nilsson G, Hedberg P, Jonasson T, Lonnberg I, Ohrvik J: QTc interval and survival in 75- year-old men and women from the general population. Europace 2006; 8: 233-240.
16. Elming H, Holm E, Jun L, Torp-Pedersen C, Kober L, Kircshoff M, Malik M, Camm J: The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998; 19: 1391- 1400.
17. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE: Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J 1999; 20: 278-284.
18. Robbins J, Nelson JC, Rautaharju PM, Gottdiener JS: The association between the length of the QT interval and mortality in the cardiovascular health study. Am J Med 2003; 115: 689-694.
19. van Noord C, Straus SM, Sturkenboom MC, Hofman A, Aarnoudse AJ, Bagnardi V, Kors JA, Newton-Cheh C, Witteman JC, Stricker BH: Psychotropic drugs associated with corrected QT interval prolongation. J Clin Psychopharmacol 2009; 29: 9-15.
20. Straus SM, Bleumink GS, Dieleman JP, van der Lei J, 't Jong GW, Kingma JH, Sturkenboom MC, Stricker BH: Antipsychotics and the risk of sudden cardiac death. Arch Intern Med 2004; 164: 1293-1297.
21. Haddad PM, Anderson IM: Antipsychoticrelated QTc prolongation, torsade de pointes and sudden death. Drugs 2002; 62: 1649-1671.
22. Zareba W, Lin DA: Antipsychotic drugs and QT interval prolongation. Psychiatr Q 2003; 74: 291-306.
23. Leitch A, McGinness P, Wallbridge D: Calculate the QT interval in patients taking drugs for dementia. BMJ 2007; 335: 557.
24. Fisher AA, Davis MW: Prolonged QT interval, syncope, and delirium with galantamine. Ann Pharmacother 2008; 42: 278-283.
25. Nelson MW, Buchanan RW: Galantamineinduced QTc prolongation. J Clin Psychiatry 2006; 67: 166-167.
26. Oka H, Mochio S, Sato H, Katayama K: Prolongation of QTc interval in patients with Parkinson's disease. Eur Neurol 1997; 37: 186-189.
27. Oka HYM, Morita M, Mochio S, Inoue K: Cardiac sympathetic dysfunction in Parkinson's disease: relationship between the results of 123 I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver. Rinsho Shinkeigaku 2003; 43: 465-469.
28. Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
29. Ishizaki F, Harada T, Yoshinaga H, Nakayama T, Yamamura Y, Nakamura S: Prolonged QTc intervals in Parkinson's disease: relation to sudden death and autonomic dysfunction (in Japanese). No To Shinkei 1996; 48: 443-448.
30. Aarsland D, Ballard CG, Halliday G: Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol 2004; 17: 137-145. (Pubitemid 39128223)
31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
32. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDSAIREN international workshop. Neurology 1993; 43: 250-260.
33. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups. J Neurol Neurosurg Psychiatry 1994; 57: 416-418.
34. Jorm AF, Jacomb PA: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989; 19: 1015-1022.
35. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632-637.
36. Alves G, Müller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, Tysnes OB, Larsen JP: Incidence of Parkinson's disease in Norway. The Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2009; 80: 851-857.
37. Garson A Jr: How to measure the QT interval - what is normal? Am J Cardiol 1993; 72: 14B- 16B.
38. Bazett HC: An analysis of time relations of the electrocardiogram. Heart 1920; 7: 353-370.
39. US Food and Drug Administration: Guidance for Industry: E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. Rockville, Center for Drug Evaluation and Research, 2005.
40. Bednar MM, Harrigan EP, Ruskin JN: Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc. Am J Cardiol 2002; 89: 1316-1319.
41. Gupta V, Lipsitz LA: Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med 2007; 120: 841-847.
42. Deguchi K, Sasaki I, Tsukaguchi M, Kamoda M, Touge T, Takeuchi H, Kuriyama S: Abnormalities of rate-corrected QT intervals in Parkinson's disease: a comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Sci 2002; 199: 31-37.
43. Halliday G, Hely M, Reid W, Morris J: The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 2008; 115: 409-415.
44. Zipes DP: The long QT interval syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 1991; 84: 1414-1419.
45. Estorch M, Camacho V, Paredes P, Rivera E, Rodriguez-Revuelto A, Flotats A, Kulisevsky J, Carrio I: Cardiac 123 I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. Eur J Nucl Med Mol Imaging 2008; 35: 1636-1641.
46. Fujishiro H, Frigerio R, Burnett M, Klos KJ, Josephs KA, Delledonne A, Parisi JE, Ahlskog JE, Dickson DW: Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov Disord 2008; 23: 1085-1092.
47. Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H: Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 2008; 131: 642-650.
48. Passant U, Warkentin S, Gustafson L: Orthostatic hypotension and low blood pressure in organic dementia: a study of prevalence and related clinical characteristics. Int J Geriatr Psychiatry 1997; 12: 395-403.
49. Molnar J, Weiss J, Zhang F, Rosenthal JE: Evaluation of five QT correction formulas using a software-assisted method of continuous QT measurement from 24-hour Holter recordings. Am J Cardiol 1996; 78: 920-926.
50. Tinetti ME, Williams TF, Mayewski R: Fall risk index for elderly patients based on number of chronic disabilities. Am J Med 1986; 80: 429-434.
51. Peralta C, Stampfer-Kountchev M, Karner E, Kollensperger M, Geser F, Wolf E, Seppi K, Benke T, Poewe W, Wenning GK: Orthostatic hypotension and attention in Parkinson's disease with and without dementia. J Neural Transm 2007; 114: 585-588.
52. Verwoert GC, Mattace-Raso FU, Hofman A, Heeringa J, Stricker BH, Breteler MM, Witteman JC: Orthostatic hypotension and risk of cardiovascular disease in elderly people: The Rotterdam study. J Am Geriatr Soc 2008; 56: 1816-1820.